The state has recorded 3,000 new cases for five of the past six days. Hospitals are going into this current surge with beds already filled to near capacity.

A study led by researchers at the University of Arizona Health Sciences shows disparities in breast cancer treatments for Indigenous women. The paper was recently published in Annals of Surgical Oncology and found American Indian and Alaska Native women with early-stage cancer were more likely to receive a mastectomy compared to white women, and less likely to receive a lumpectomy than white women.

Ricardo Correa, MD, program director of the endocrinology, diabetes and metabolism fellowship at the College of Medicine – Phoenix, discusses the importance of minority hiring in healthcare.

Interview with Jonathan Lifshitz, PhD, director of the translational neurotrauma research program at the College of Medicine – Phoenix, about his latest research into traumatic brain injuries and how they can affect an unborn child's development.

Average daily cases of COVID-19 have risen faster in Arizona than the wide majority of states over the previous two weeks, ranking in the top seven states across the country, according to data compiled by the New York Times as of Nov. 5.

The gift establishes endowed positions and scholarships and expands the History of Pharmacy Museum. The College renaming recognizes R. Ken Coit's support.

In the past few weeks Arizona attorney general Mark Brnovich, who is also running for U.S. Senate, has begun casting doubt on vaccine effectiveness far more openly.

Joel A. Dvoskin, PhD, a clinical assistant professor of psychiatry at the College of Medicine – Tucson, says reducing gun ownership to levels seen in peer countries is "literally impossible."

Rick Schnellmann, PhD, dean of the College of Pharmacy, announced a $50 million gift the college has received from UArizona alumnus R. Ken Coit. The college has been officially renamed the R. Ken Coit College of Pharmacy.

Copper has long been known to be antibacterial, but research led by Michael D. L. Johnson, PhD, shows how a special compound can be bound to copper to kill even antibiotic-resistant pathogens.